Lentinan is a beta-glucan (a type of polysaccharide) from the mushroom lentinus edodes (shiitake mushroom). It has been studied in Japan as a treatment for cancer.
As an intravenous biological response modifier, lentinan features potent antitumor effects, remarkably prolonged life, improved life quality and mild side effects. First developed by Japan, lentinan was approved to enter China in 1988. Although the practical use has confirmed lentinan’s efficacy, its market size has been limited due to its high price. After entering the 21st century, lentinan has become able to be produced domestically at a relatively low price. Therefore, its market size grows at an increasing rate. Now, China is the dominate producer of lentinan, the production is 84528 Kg in 2015, according for about 67.85% of the total amount, followed by Japan, with the production market share of 15.72%. China also has the highest production growth rate of 6.00% from 2011 to 2015. Even though a huge space for growth in the Chinese market exists, the quality and technology should further improve.
Market Analysis and Insights: Global Lentinan Market
The global Lentinan market was valued at US$ 10 in 2020 and will reach US$ 12 million by the end of 2027, growing at a CAGR of 3.3% during 2022-2027.
Global Lentinan Scope and Market Size
The global Lentinan market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Lentinan market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Food Grade
Pharmaceutical Grade
Other
Segment by Application
Food additive
Health product field
Anti-cancer drug
Others
The Lentinan market is analysed and market size information is provided by regions (countries). Segment by Application, the Lentinan market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Ajinomoto
Elicityl
Nammex
Panjin Gerun Biotech
Golden Horizon Biologics
Acetar Bio-Tech
Johncan Mushroom Bio-technology
Xi'an Changyue Phychemistry
Xi'an Yuansun Biological
As an intravenous biological response modifier, lentinan features potent antitumor effects, remarkably prolonged life, improved life quality and mild side effects. First developed by Japan, lentinan was approved to enter China in 1988. Although the practical use has confirmed lentinan’s efficacy, its market size has been limited due to its high price. After entering the 21st century, lentinan has become able to be produced domestically at a relatively low price. Therefore, its market size grows at an increasing rate. Now, China is the dominate producer of lentinan, the production is 84528 Kg in 2015, according for about 67.85% of the total amount, followed by Japan, with the production market share of 15.72%. China also has the highest production growth rate of 6.00% from 2011 to 2015. Even though a huge space for growth in the Chinese market exists, the quality and technology should further improve.
Market Analysis and Insights: Global Lentinan Market
The global Lentinan market was valued at US$ 10 in 2020 and will reach US$ 12 million by the end of 2027, growing at a CAGR of 3.3% during 2022-2027.
Global Lentinan Scope and Market Size
The global Lentinan market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Lentinan market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Food Grade
Pharmaceutical Grade
Other
Segment by Application
Food additive
Health product field
Anti-cancer drug
Others
The Lentinan market is analysed and market size information is provided by regions (countries). Segment by Application, the Lentinan market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Ajinomoto
Elicityl
Nammex
Panjin Gerun Biotech
Golden Horizon Biologics
Acetar Bio-Tech
Johncan Mushroom Bio-technology
Xi'an Changyue Phychemistry
Xi'an Yuansun Biological
Frequently Asked Questions
This market study covers the global and regional market with an
in-depth analysis of the
overall growth prospects...
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by
highlighting information on
different aspects including drivers, restraints...
Pre-order Enquiry
Download Free Sample








